IDO1 and neoplasm: Therefore, in inflammatory or tumor environments, increased IDO activity not only reduces the synthesis of 5-HT, leading to depressive symptoms, but also increases levels of KYN and its neurotoxic metabolites (such as QUIN), negatively affecting the nervous system.